|
|||||
|
|
Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) in the real-world setting |
|
| Affiliation: | 1. Department of Hematology, Medical Center Leeuwarden, Leeuwarden;2. Department of Pathology, Pathology Friesland, Leeuwarden;3. Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands |
| Abstract: | |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ | |